Glenn Matfin

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi request reprint Erectile dysfunction: interrelationship with the metabolic syndrome
    Glenn Matfin
    Global Clinical Research, Novartis Pharmaceuticals, One Health Plaza, East Hanover, NJ 07936 1080, USA
    Curr Diab Rep 5:64-9. 2005
  2. ncbi request reprint New treatments for erectile dysfunction
    Glenn Matfin
    Waltham, MA 02453, USA
    Fertil Steril 80:40-5; quiz 54-56. 2003
  3. ncbi request reprint Challenges in developing drugs for the metabolic syndrome
    Glenn Matfin
    Global Medical and Scientific Affairs, Takeda America Holdings, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Diab Rep 8:31-6. 2008

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Erectile dysfunction: interrelationship with the metabolic syndrome
    Glenn Matfin
    Global Clinical Research, Novartis Pharmaceuticals, One Health Plaza, East Hanover, NJ 07936 1080, USA
    Curr Diab Rep 5:64-9. 2005
    ....
  2. ncbi request reprint New treatments for erectile dysfunction
    Glenn Matfin
    Waltham, MA 02453, USA
    Fertil Steril 80:40-5; quiz 54-56. 2003
    ..The pathophysiology of ED is becoming better understood, largely as a result of the development of new therapies. Once the underlying processes are known, more selective targeting of these will lead to novel "designer drugs."..
  3. ncbi request reprint Challenges in developing drugs for the metabolic syndrome
    Glenn Matfin
    Global Medical and Scientific Affairs, Takeda America Holdings, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Diab Rep 8:31-6. 2008
    ..To date, no drugs are approved specifically for treating the metabolic syndrome. This article discusses some of the challenges in developing therapies for the metabolic syndrome...